(R)-1,1,1-trifluoro-2-(4-((S)-2-(((S)-3-methylmorpholino)methyl)-4-(thiophen-2-ylsulfonyl)piperazin-1-yl)phenyl)propan-2-ol

ID: ALA3113979

Cas Number: 1361217-07-3

PubChem CID: 66582747

Max Phase: Preclinical

Molecular Formula: C23H30F3N3O4S2

Molecular Weight: 533.64

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C[C@H]1COCCN1C[C@H]1CN(S(=O)(=O)c2cccs2)CCN1c1ccc([C@@](C)(O)C(F)(F)F)cc1

Standard InChI:  InChI=1S/C23H30F3N3O4S2/c1-17-16-33-12-11-27(17)14-20-15-28(35(31,32)21-4-3-13-34-21)9-10-29(20)19-7-5-18(6-8-19)22(2,30)23(24,25)26/h3-8,13,17,20,30H,9-12,14-16H2,1-2H3/t17-,20-,22+/m0/s1

Standard InChI Key:  OJTJLEFGCNYTBQ-RBDMOPTHSA-N

Molfile:  

     RDKit          2D

 35 38  0  0  0  0  0  0  0  0999 V2000
    6.8291   -4.9097    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6523   -4.9108    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0630   -4.1997    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6517   -3.4869    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8254   -3.4897    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4184   -4.2014    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8880   -4.1999    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3003   -4.9145    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3007   -3.4856    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1256   -3.4857    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    8.8883   -2.7709    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    9.7082   -2.7667    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    9.7124   -4.1958    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.5949   -4.2027    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.1815   -3.4877    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3601   -3.4882    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9459   -4.2020    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.3593   -4.9171    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1869   -4.9183    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6009   -5.6320    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1898   -6.3472    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.3654   -6.3444    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9544   -7.0555    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3648   -7.7716    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.1908   -7.7720    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6063   -7.0562    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4313   -7.0541    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1209   -4.2014    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    2.7078   -4.9156    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2958   -4.1999    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.7042   -3.4833    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.8867   -5.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7145   -5.8068    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4288   -6.2199    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0422   -5.6683    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  3  7  1  0
  7  8  1  0
  7  9  1  1
  9 10  1  0
  9 11  1  0
  9 12  1  0
  7 13  1  0
 14 15  1  0
 14 19  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
  6 14  1  0
 19 20  1  1
 20 21  1  0
 21 22  1  0
 21 26  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  1
 17 28  1  0
 28 29  1  0
 28 30  2  0
 28 31  2  0
 29 32  2  0
 32 33  1  0
 33 34  2  0
 34 35  1  0
 35 29  1  0
M  END

Associated Targets(Human)

Liver microsome (8277 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GCK Tchem Hexokinase type IV (3191 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GCKR Tchem Glucokinase regulatory protein (190 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Gck Glucokinase (92 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver microsome (4459 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasma (10718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Gckr Glucokinase regulatory protein (18 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 533.64Molecular Weight (Monoisotopic): 533.1630AlogP: 3.12#Rotatable Bonds: 6
Polar Surface Area: 73.32Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 10.86CX Basic pKa: 6.35CX LogP: 3.52CX LogD: 3.48
Aromatic Rings: 2Heavy Atoms: 35QED Weighted: 0.62Np Likeness Score: -1.50

References

1. St Jean DJ, Ashton KS, Bartberger MD, Chen J, Chmait S, Cupples R, Galbreath E, Helmering J, Hong FT, Jordan SR, Liu L, Kunz RK, Michelsen K, Nishimura N, Pennington LD, Poon SF, Reid D, Sivits G, Stec MM, Tadesse S, Tamayo N, Van G, Yang KC, Zhang J, Norman MH, Fotsch C, Lloyd DJ, Hale C..  (2014)  Small molecule disruptors of the glucokinase-glucokinase regulatory protein interaction: 2. Leveraging structure-based drug design to identify analogues with improved pharmacokinetic profiles.,  57  (2): [PMID:24405213] [10.1021/jm4016747]
2. Ashton KS, Andrews KL, Bryan MC, Chen J, Chen K, Chen M, Chmait S, Croghan M, Cupples R, Fotsch C, Helmering J, Jordan SR, Kurzeja RJ, Michelsen K, Pennington LD, Poon SF, Sivits G, Van G, Vonderfecht SL, Wahl RC, Zhang J, Lloyd DJ, Hale C, St Jean DJ..  (2014)  Small molecule disruptors of the glucokinase-glucokinase regulatory protein interaction: 1. Discovery of a novel tool compound for in vivo proof-of-concept.,  57  (2): [PMID:24405172] [10.1021/jm4016735]

Source